Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas

Hanna Lee, Hwanseok Rhee, Hyun Ju Kang, Hyon Suk Kim, Byung Soh Min, Nam Kyu Kim, Hoguen Kim

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Recent genetic studies have identified many differentially expressed genes in colorectal carcinomas. For validation of up-regulated genes in colorectal carcinomas, we performed an enzyme-linked immunosorbent assay. Candidate markers were selected from gene expression data for 40 colorectal cancers and 35 matched normal mucosal samples. Based on intensive filtering, 9 genes were selected for the further evaluations. Among them, macrophage migration inhibitory factor (MIF), inhibin βA, and chemokine ligand 10 were screened, and the results were compared with carcinoembryonic antigen (CEA) in serum samples of 129 patients with colon cancer and 53 healthy control subjects. We found that the serum MIF level was significantly increased in patients with colorectal cancer. Compared with CEA, MIF was more sensitive in early cancer detection (47.3% vs 29.5%). However, the specificity was not as high as that of CEA (90.6% vs 100.0%). Our findings indicate that MIF may be used as a diagnostic marker in colorectal carcinomas.

Original languageEnglish
Pages (from-to)772-779
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume129
Issue number5
DOIs
Publication statusPublished - 2008 May 1

Fingerprint

Macrophage Migration-Inhibitory Factors
Colorectal Neoplasms
Carcinoembryonic Antigen
Genes
Serum
Early Detection of Cancer
Chemokines
Colonic Neoplasms
Healthy Volunteers
Enzyme-Linked Immunosorbent Assay
Ligands
Gene Expression

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Lee, Hanna ; Rhee, Hwanseok ; Kang, Hyun Ju ; Kim, Hyon Suk ; Min, Byung Soh ; Kim, Nam Kyu ; Kim, Hoguen. / Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas. In: American Journal of Clinical Pathology. 2008 ; Vol. 129, No. 5. pp. 772-779.
@article{c3399541aedf437fafd042456a03808f,
title = "Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas",
abstract = "Recent genetic studies have identified many differentially expressed genes in colorectal carcinomas. For validation of up-regulated genes in colorectal carcinomas, we performed an enzyme-linked immunosorbent assay. Candidate markers were selected from gene expression data for 40 colorectal cancers and 35 matched normal mucosal samples. Based on intensive filtering, 9 genes were selected for the further evaluations. Among them, macrophage migration inhibitory factor (MIF), inhibin βA, and chemokine ligand 10 were screened, and the results were compared with carcinoembryonic antigen (CEA) in serum samples of 129 patients with colon cancer and 53 healthy control subjects. We found that the serum MIF level was significantly increased in patients with colorectal cancer. Compared with CEA, MIF was more sensitive in early cancer detection (47.3{\%} vs 29.5{\%}). However, the specificity was not as high as that of CEA (90.6{\%} vs 100.0{\%}). Our findings indicate that MIF may be used as a diagnostic marker in colorectal carcinomas.",
author = "Hanna Lee and Hwanseok Rhee and Kang, {Hyun Ju} and Kim, {Hyon Suk} and Min, {Byung Soh} and Kim, {Nam Kyu} and Hoguen Kim",
year = "2008",
month = "5",
day = "1",
doi = "10.1309/GFCLLRH8A68XKMJN",
language = "English",
volume = "129",
pages = "772--779",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "5",

}

Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas. / Lee, Hanna; Rhee, Hwanseok; Kang, Hyun Ju; Kim, Hyon Suk; Min, Byung Soh; Kim, Nam Kyu; Kim, Hoguen.

In: American Journal of Clinical Pathology, Vol. 129, No. 5, 01.05.2008, p. 772-779.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas

AU - Lee, Hanna

AU - Rhee, Hwanseok

AU - Kang, Hyun Ju

AU - Kim, Hyon Suk

AU - Min, Byung Soh

AU - Kim, Nam Kyu

AU - Kim, Hoguen

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Recent genetic studies have identified many differentially expressed genes in colorectal carcinomas. For validation of up-regulated genes in colorectal carcinomas, we performed an enzyme-linked immunosorbent assay. Candidate markers were selected from gene expression data for 40 colorectal cancers and 35 matched normal mucosal samples. Based on intensive filtering, 9 genes were selected for the further evaluations. Among them, macrophage migration inhibitory factor (MIF), inhibin βA, and chemokine ligand 10 were screened, and the results were compared with carcinoembryonic antigen (CEA) in serum samples of 129 patients with colon cancer and 53 healthy control subjects. We found that the serum MIF level was significantly increased in patients with colorectal cancer. Compared with CEA, MIF was more sensitive in early cancer detection (47.3% vs 29.5%). However, the specificity was not as high as that of CEA (90.6% vs 100.0%). Our findings indicate that MIF may be used as a diagnostic marker in colorectal carcinomas.

AB - Recent genetic studies have identified many differentially expressed genes in colorectal carcinomas. For validation of up-regulated genes in colorectal carcinomas, we performed an enzyme-linked immunosorbent assay. Candidate markers were selected from gene expression data for 40 colorectal cancers and 35 matched normal mucosal samples. Based on intensive filtering, 9 genes were selected for the further evaluations. Among them, macrophage migration inhibitory factor (MIF), inhibin βA, and chemokine ligand 10 were screened, and the results were compared with carcinoembryonic antigen (CEA) in serum samples of 129 patients with colon cancer and 53 healthy control subjects. We found that the serum MIF level was significantly increased in patients with colorectal cancer. Compared with CEA, MIF was more sensitive in early cancer detection (47.3% vs 29.5%). However, the specificity was not as high as that of CEA (90.6% vs 100.0%). Our findings indicate that MIF may be used as a diagnostic marker in colorectal carcinomas.

UR - http://www.scopus.com/inward/record.url?scp=44849135902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44849135902&partnerID=8YFLogxK

U2 - 10.1309/GFCLLRH8A68XKMJN

DO - 10.1309/GFCLLRH8A68XKMJN

M3 - Article

C2 - 18426738

AN - SCOPUS:44849135902

VL - 129

SP - 772

EP - 779

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 5

ER -